-
Merck & Co. has initiated a voluntary recall in the United States for 10 lots of PedvaxHIB® [Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)] and two lots of COMVAX® [Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine].
-
The Michigan Health & Hospital Association's Keystone Center for Patient Safety & Quality has created a "bladder bundle" of measures to prevent urinary tract infections. Some of the key recommendations for implementation of the bundle are summarized as follows:
-
-
A recent controversial move by a federal health agency to shut down a highly successful infection prevention program because it appeared to be involved in human research rather than quality improvement has ominous implications for traditional infection control activities, a leading epidemiologist tells Hospital Infection Control.
-
The Centers for Disease Control and Prevention in conjunction with Kaiser Permanente's Northern California Division of Research will formally investigate an unexplained but persistently reported skin condition known as Morgellons.
-
Clinical trial investigators and sites increasingly may need to rely on recruitment experts in coming years as community-based research increases and the industry evolves.
-
The informed consent process is more challenging because of the public's lack of understanding and trust of research.
-
Clinical research professionals at Summa Health System in Akron, OH, have found that some details on recruitment materials can make a big difference in how potential research participants view a clinical trial.
-
-
Clinical trial sites and research professionals should be cautious and learn from their peers' mistakes to prevent clinical research (CR) litigation, experts say.
